Building a Swiss Pain Registry: A National Framework for Acute and Chronic Pain Assessment

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

The goal of this observational registry is to systematically collect and analyse real-world clinical and patient-reported data in individuals receiving treatment for acute and chronic pain. The main questions it aims to answer are: How do pain intensity, functional status, and quality of life evolve over time in patients with acute and chronic pain? How are different routine clinical treatment approaches associated with patient-reported outcomes in real-world clinical practice? Participants already receiving standard care for pain management will have routine clinical data recorded as part of their treatment and will be asked to complete standardized questionnaires on pain intensity, functional status, and quality of life at multiple time points during treatment and follow-up. Data are collected using a secure electronic system and are pseudonymised prior to analysis in accordance with Swiss data protection regulations.

Eligibility criteria

Qualifiers

Signed informed consent by the participant or legal guardian for minors.

Diagnosis of acute or chronic pain (chronic pain defined as pain lasting ≥ 3 months), including nociceptive, neuropathic, or mixed pain conditions.

Referral for interdisciplinary outpatient pain assessment or treatment.

Sufficient proficiency in German, French, Italian, or English to complete digital assessments (parental proxy allowed for paediatric participants if needed).

Disqualifiers

Lack of capacity to provide informed consent or absence of a legal guardian for minors.

Inability to understand study languages and complete assessments even with assistance.

Acute life-threatening conditions precluding participation.

Site-specific safety considerations as determined by treating clinician.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 1 trial group